Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
The Journal of Clinical Investigation
|
November 22, 2014
mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity
Catherine E Gleason, Gustavo Frindt, Chih-Jen Cheng, et al.
The Journal of Biological Chemistry
|
April 18, 2021
Role of mTORC2 in biphasic regulation of brown fat metabolism in response to mild and severe cold
Prasanna K R Allu, Esther Paulo, Ambre M Bertholet, et al.
The Journal of Biological Chemistry
|
August 4, 2022
Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt
Zanlin Yu, Junliang Chen, Enzo Takagi, et al.
Scientific Reports
|
February 3, 2018
Non-invasive detection of divergent metabolic signals in insulin deficiency vs. insulin resistance in vivo
Cornelius von Morze, Prasanna K R Allu, Gene Y Chang, et al.
Journal of Medicinal Chemistry
|
February 21, 2026
Orally Bioavailable Cyclin A/B RxL Inhibitors: Optimization of a Novel Class of Macrocyclic Peptides That Target E2F-High and G1-S-Checkpoint-Compromised Cancers
Justin A Shapiro, Nathan J Dupper, Breena Fraga-Walton, et al.
Journal of Medicinal Chemistry
|
August 14, 2025
Discovery of Cell-Permeable Macrocyclic Cyclin A/B RxL Inhibitors that Demonstrate Antitumor Activity
Andrew T Bockus, Siegfried S F Leung, Breena Fraga-Walton, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity
Shilpa Singh, Catherine E Gleason, Min Fang, et al.
Nature
|
August 20, 2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors
Shilpa Singh, Catherine E Gleason, Min Fang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
The Journal of Clinical Investigation
|
November 22, 2014
mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity
Catherine E Gleason, Gustavo Frindt, Chih-Jen Cheng, et al.
The Journal of Biological Chemistry
|
April 18, 2021
Role of mTORC2 in biphasic regulation of brown fat metabolism in response to mild and severe cold
Prasanna K R Allu, Esther Paulo, Ambre M Bertholet, et al.
The Journal of Biological Chemistry
|
August 4, 2022
Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt
Zanlin Yu, Junliang Chen, Enzo Takagi, et al.
Scientific Reports
|
February 3, 2018
Non-invasive detection of divergent metabolic signals in insulin deficiency vs. insulin resistance in vivo
Cornelius von Morze, Prasanna K R Allu, Gene Y Chang, et al.
Journal of Medicinal Chemistry
|
February 21, 2026
Orally Bioavailable Cyclin A/B RxL Inhibitors: Optimization of a Novel Class of Macrocyclic Peptides That Target E2F-High and G1-S-Checkpoint-Compromised Cancers
Justin A Shapiro, Nathan J Dupper, Breena Fraga-Walton, et al.
Journal of Medicinal Chemistry
|
August 14, 2025
Discovery of Cell-Permeable Macrocyclic Cyclin A/B RxL Inhibitors that Demonstrate Antitumor Activity
Andrew T Bockus, Siegfried S F Leung, Breena Fraga-Walton, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity
Shilpa Singh, Catherine E Gleason, Min Fang, et al.
Nature
|
August 20, 2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors
Shilpa Singh, Catherine E Gleason, Min Fang, et al.
Page
of 2